Patents by Inventor Lili Qu

Lili Qu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067747
    Abstract: Provided is an isolated antigen-binding protein, which can specifically bind to CD73 and includes at least one CDR in a heavy chain variable region VH, wherein the region VH includes an amino acid sequence as represented by SEQ ID NO: 49.
    Type: Application
    Filed: January 12, 2022
    Publication date: February 29, 2024
    Inventors: Jingen XU, Xiangyang ZHU, Haijia YU, Xiaoyue WEI, Lili QU, Xiaochen REN
  • Publication number: 20230399409
    Abstract: The present application provides an antibody targeting interleukin 36R, a preparation method therefor, and an application thereof. Specifically, the present application provides an IL-36R antibody having high affinity and high bioactivity. The antibody can bind to IL-36R with high affinity, and can block the binding between an IL-36R ligand (?, ?. ?) and the IL-36R and a signal path activated by the IL-36R ligand, thereby treating and/or preventing IL-36 related diseases.
    Type: Application
    Filed: November 4, 2021
    Publication date: December 14, 2023
    Inventors: Yujie FENG, Haijia YU, Xiaoyue WEI, Guoyuan PENG, Shi CHEN, Lili QU
  • Patent number: 9273095
    Abstract: Disclosed are an antibiotic peptide and the like, having an amino acid sequence of Ac-Phe-Lys-Lys-Leu-Lys-Lys-Leu-Phe-Ser-Lys-Leu-Trp-Asn-Trp-Lys-NH2 (SEQ ID No:2). Also disclosed are a method of preparing the antibiotic peptide and the like, and the application thereof. The antibiotic peptide and the like synthesized by the solid phase synthetic technology according to the present invention can be used as a formulation against microbial infection and as alternate or adjuvant medicaments of antibiotics in the prior art.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: March 1, 2016
    Assignee: Jiangsu Protelight Pharmaceutical & Biotechnology Co., Ltd.
    Inventors: Yuxin Chen, Mingxia Chen, Yibing Huang, Yang Li, Yong Wang, Lili Qu, Wenren Wang
  • Publication number: 20140329739
    Abstract: Disclosed are an antibiotic peptide and the like, having an amino acid sequence of Ac-Phe-Lys-Lys-Leu-Lys-Lys-Leu-Phe-Ser-Lys-Leu-Trp-Asn-Trp-Lys-NH2 (SEQ ID No:1). Also disclosed are a method of preparing the antibiotic peptide and the like, and the application thereof. The antibiotic peptide and the like synthesized by the solid phase synthetic technology according to the present invention can be used as a formulation against microbial infection and as alternate or adjuvant medicaments of antibiotics in the prior art.
    Type: Application
    Filed: January 17, 2012
    Publication date: November 6, 2014
    Applicant: JIANGSU PROTELIGHT PHARMACEUTICAL & BIOTECHNOLOGY CO., LTD.
    Inventors: Yuxin Chen, Mingxia Chen, Yibing Huang, Yang Li, Yong Wang, Lili Qu, Wenren Wang